Global Radiotherapy Market - Industry Trends and Forecast to 2030

Global Radiotherapy Market - Industry Trends and Forecast to 2030

The global radiotherapy market is projected to register a CAGR of 8.5% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.

Market Segmentation
Global Radiotherapy Market, By Product and Services (Services, Product, and Software), Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/ Radiopharmaceuticals, and Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, and Others), End User (Hospitals, Radiation Therapy Centres, Specialty Clinics, and Others), Distribution Channel (Direct Tenders, Third Party Distributors, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Ukraine, rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, Chile, rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt, and rest of Middle East and Africa) - Industry Trends and Forecast to 2030

Overview of Global Radiotherapy Market Dynamics

Driver
• Growing prevalence of cancer disease

Restraint

• Lack of skilled and certified professionals

Opportunity

• Increasing healthcare expenditure for cancer treatment

Market Players

Some of the major market players operating in the global radiotherapy market are:
• Varian Medical Systems, Inc.
• Mevion Medical Systems
• VIEWRAY TECHNOLOGIES, INC. (A Subsidiary of ViewRay)
• Siemens Healthcare GmbH
• Elekta AB
• Accuray Incorporated
• IBA Worldwide
• Eckert & Ziegler BEBIG
• RaySearch Laboratories
• Brainlab AG
• Koninklijke Philips N.V.
• GE Healthcare
• Hitachi, Ltd.
• Isoray Inc